spinal fusion
-
Biologics
Kuros Biosciences Announces U.S. FDA approval of IND Application to Initiate Fibrin-PTH Phase 2a Clinical Trial in Spinal Fusion
Kuros to conduct Phase 2a trial in spinal fusion, comparing Fibrin-PTH to autograftPrimary endpoint is radiographic interbody fusion at 12 months SCHLIEREN…
Read More » -
Biologics
Celling Spine Acquires Assets of Link Spine to Further Develop and Promote a Cell Centric Spine Platform
AUSTIN, Texas, July 1, 2019 /PRNewswire/ — Celling Spine (“Celling”) a subsidiary of Celling Biosciences, based in Austin, Texas, acquired all the assets of…
Read More » -
Spine
New Study Finds Plasmapore®XP Surface Enhancement Demonstrates Enhanced Osseointegrative Properties
CENTER VALLEY, Pa., Jan. 28, 2019 /PRNewswire/ — Aesculap Implant Systems, LLC today announced the publication of “Porous titanium-coated polyetheretherketone implants exhibit an…
Read More » -
Biologics
Kuros Reports Publication of MagnetOs Data Demonstrating Equivalence to Autologous Bone in Spinal Fusion
SCHLIEREN (ZURICH), Switzerland, Dec. 06, 2018 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced the publication of data from…
Read More » -
Financial
Global Spine Market to Reach $18 Billion by 2023 According to New Analysis by iData Research
September 13, 2018 VANCOUVER, British Columbia–(BUSINESS WIRE)–According to a new series of reports by iData Research, the global spine market…
Read More » -
Biologics
Burst Biologics Initiates Prospective Multicenter Clinical Study in Spinal Fusion
March 28, 2017 BOISE, Idaho–(BUSINESS WIRE)–Burst Biologics has received IRB approval to begin a multicenter prospective clinical study in spinal…
Read More » -
Spine
Amedica and Celling Biosciences to Collaborate on Biologically Enhanced Spinal Fusion Devices
Amedica’s Silicon Nitride Performed 400% Better Than PEEK in Recent Cell Adhesion Study SALT LAKE CITY, March 02, 2016 (GLOBE NEWSWIRE) — Amedica…
Read More » -
Spine
New spinal fusion system going to human trials in Australia: 5 key notes
By Laura Dyrda Researchers at the University of New South Wales in Australia are developing and testing the Thru-Fuze device…
Read More » -
Spine
5 things to know about short-term morbidity for neuromuscular scoliosis surgery patients
By Laura Dyrda A new study published in Spine examined the risk factors for short-term morbidity after posterior spinal fusion…
Read More » -
Spine
Does spinal fusion union rate make a difference? 5 things to know
By Laura Dyrda A new study published in Spine examines fusion rate for patients undergoing spinal fusion with rhBMP-2 or fusion with iliac crest…
Read More » -
Spine
Disc replacement vs. spinal fusion: 5 key notes on 18 RTCs
By Laura Dyrda A new meta-analysis published in Spine examines the randomized controlled trials involving cervical disc arthroplasty compared with anterior cervical…
Read More » -
Spine
5 key notes on the BMP-2/cancer connection in spinal fusion
By Laura Dyrda A new study published in Spine examines the association between BMP-2 and carcinogenicity for spinal fusion patients. The researchers reviewed 4,131…
Read More » -
Spine
ProDisc-C vs. spinal fusion: Which has better results? 5 key notes
By Laura Dyrda The ProDisc-C total disc replacement was compared with single-level anterior cervical discectomy and fusion in a new…
Read More » -
Spine
8 things for spine surgeons to know
By Megan Wood Here are eight things for spinal surgeons to know for Nov. 19, 2015. Spinal fusions with BMP…
Read More »